BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21370594)

  • 1. Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancer.
    Faluyi OO; Gourley C; Smyth JF; Faratian D; Williams AR; Rye T; Rye R; Stewart M; Mackean MJ
    Int J Gynecol Cancer; 2010 Dec; 20(9):1511-7. PubMed ID: 21370594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metastases from epithelial ovarian carcinoma: evaluation of prognosis and managements - a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Chiang YC; Qiu JT; Chang CL; Wang PH; Ho CM; Lin WC; Huang YF; Lin H; Lu CH; Chou CY
    Gynecol Oncol; 2012 Apr; 125(1):37-41. PubMed ID: 22198245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system metastases from epithelial ovarian cancer: prognostic factors and outcomes.
    Cormio G; Loizzi V; Falagario M; Calace A; Colamaria A; De Tommasi A; Selvaggi LE
    Int J Gynecol Cancer; 2011 Jul; 21(5):816-21. PubMed ID: 21613959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
    Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
    Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy.
    Kastritis E; Efstathiou E; Gika D; Bozas G; Koutsoukou V; Papadimitriou C; Pissakas G; Dimopoulos MA; Bamias A
    Int J Gynecol Cancer; 2006; 16(3):994-9. PubMed ID: 16803475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases in women with epithelial ovarian cancer: multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival.
    Niu X; Rajanbabu A; Delisle M; Peng F; Vijaykumar DK; Pavithran K; Feng Y; Lau S; Gotlieb WH; Press JZ
    J Obstet Gynaecol Can; 2013 Sep; 35(9):816-822. PubMed ID: 24099447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
    Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
    Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metastases as late breast cancer relapse. Single institution experience and review of the literature.
    Tomasevic Z; Radosevic-Jelic Lj; Jovanovic D; Milovanovic Z; Tomasevic ZM; Jelic S; Borojevic N
    J BUON; 2009; 14(2):225-8. PubMed ID: 19650170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer].
    Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
    Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
    Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases in epithelial ovarian carcinoma.
    Geisler JP; Geisler HE
    Gynecol Oncol; 1995 May; 57(2):246-9. PubMed ID: 7729743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort.
    Gapstur SM; Patel AV; Diver WR; Hildebrand JS; Gaudet MM; Jacobs EJ; Campbell PT
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2000-5. PubMed ID: 22941335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven cases of epithelial ovarian carcinoma with brain metastasis.
    Yang JX; Shen K; Shan Y; Lang JH; Wu M; Guo LN; Huang HF; Pan LY
    Chin Med Sci J; 2008 Mar; 23(1):19-22. PubMed ID: 18437905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
    Hunter MI; Ziogas A; Flores F; Brewster WR
    Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.
    Petrillo M; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Vizzielli G; Pedone Anchora L; Nero C; Margariti PA; Scambia G
    Gynecol Oncol; 2013 Oct; 131(1):36-41. PubMed ID: 23791829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and distribution of lymph node metastases in epithelial ovarian cancer.
    Haller H; Mamula O; Krasevic M; Rupcic S; Fischer AB; Eminovic S; Manestar M; Perovic D
    Int J Gynecol Cancer; 2011 Feb; 21(2):245-50. PubMed ID: 21721192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor status predicts development of brain metastases in ovarian cancers.
    Mittica G; Senetta R; Scotto G; Aglietta M; Maggiorotto F; Ghisoni E; Genta S; Boldorini R; Manini C; Morra I; Buosi R; Sapino A; Cassoni P; Valabrega G
    Oncotarget; 2017 Jun; 8(25):41143-41153. PubMed ID: 28467804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second primary cancers following borderline ovarian tumors.
    Sanci M; Gultekin E; Cingillioglu B; Gultekin OE; Ozvural S; Emirdar V; Yildirim Y
    Arch Gynecol Obstet; 2011 Jun; 283(6):1391-6. PubMed ID: 20628749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.